Metal-binding therapeutic peptides
OwnerDesmond MASCARENHASinventor
Life of this patent
Estimating the term…
Abstract
The present invention is related methods of delivering MBD peptide-linked agents into live cells. The methods described herein comprise contacting MBD peptide-linked agents to live cells under a condition of cellular stress. The methods of the invention may be used for therapeutic or diagnostic purposes.
Claims9
1-36. (canceled)
A polypeptide comprising the sequence SDKPDMAPRGFSCLLLLTGEIDLPV (SEQ ID NO:245).
A method of treating an inflammatory disease condition comprising administering an effective amount of a polypeptide to a mammal, wherein said polypeptide comprises and amino acid sequence selected from the group consisting of SDKPDMAPRGFSCLLLLTGEIDLPV (SEQ ID NO:245), humanin (SEQ ID NO:188), and humanin-S14G (SEQ ID NO:189);
- and said inflammatory disease condition is selected from the group consisting of cancer, cardiomyopathy, nephropathy, retinopathy, obesity, lupus, autoimmune disease, rheumatological disease and infectious disease.
Dependencies are inferred from the claim text.